Mar 08, 2011 07:30 EST Olink Bioscience Olink Bioscience now offers a new research service, Plasma Biomarker Discovery Service. Using the multiplexed PLA® immunoassay platform, up to 74 potential cancer biomarkers are analyzed with high sensitivity in precious biobanked plasma samples, in no more than 2 µl of sample. This enables identification of novel biomarkers and contributies to the understanding of human cancer.

Sep 14, 2009 02:48 EDT Olink Bioscience Olink Bioscience and its sister company Olink Genomics is participating in the project “Companion Diagnostics Initiative” which is financed by Vinnova and aims to develop improved cancer diagnostics to increase survival rate of patients with colorectal cancer.